Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb 26;6:35.
doi: 10.1186/1471-2334-6-35.

Invasive Fungal Infections in Neutropenic Enterocolitis: A Systematic Analysis of Pathogens, Incidence, Treatment and Mortality in Adult Patients

Free PMC article

Invasive Fungal Infections in Neutropenic Enterocolitis: A Systematic Analysis of Pathogens, Incidence, Treatment and Mortality in Adult Patients

Marcus Gorschlüter et al. BMC Infect Dis. .
Free PMC article


Background: Neutropenic enterocolitis is a life-threatening complication most frequently occurring after intensive chemotherapy in acute leukaemias. Gramnegative bacteria constitute the most important group of causative pathogens. Fungi have also been reported, but their practical relevance remains unclear. The guidelines do not address concrete treatment recommendations for fungal neutropenic enterocolitis.

Methods: Here, we conducted a metaanalysis to answer the questions: What are frequency and mortality of fungal neutropenic enterocolitis? Do frequencies and microbiological distribution of causative fungi support empirical antimycotic therapy? Do reported results of antimycotic therapy in documented fungal neutropenic enterocolitis help with the selection of appropriate drugs? Following a systematic search, we extracted and summarised all detail data from the complete literature.

Results: Among 186 articles describing patients with neutropenic enterocolitis, we found 29 reports describing 53 patients with causative fungal pathogens. We found no randomised controlled trial, no good quality cohort study and no good quality case control study on the role of antifungal treatment. The pooled frequency of fungal neutropenic enterocolitis was 6.2% calculated from all 860 reported patients and 3.4% calculated from selected representative studies only. In 94% of the patients, Candida spp. were involved. The pooled mortality rate was 81.8%. Most authors did not report or perform antifungal therapy.

Conclusion: In patients with neutropenic enterocolitis, fungal pathogens play a relevant, but secondary role compared to bacteria. Evidence concerning therapy is very poor, but epidemiological data from this study may provide helpful clues to select empiric antifungal therapy in neutropenic enterocolitis.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles


    1. Gorschluter M, Mey U, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IG, Sauerbruch T, Glasmacher A. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol. 2005;75:1–13. doi: 10.1111/j.1600-0609.2005.00442.x. - DOI - PubMed
    1. Starnes HF, Jr, Moore FD, Jr, Mentzer S, Osteen RT, Steele GD, Jr, Wilson RE. Abdominal pain in neutropenic cancer patients. Cancer. 1986;57:616–21. - PubMed
    1. Villar HV, Warneke JA, Peck MD, Durie B, Bjelland JC, Hunter TB. Role of surgical treatment in the management of complications of the gastrointestinal tract in patients with leukemia. Surg Gynecol Obstet. 1987;165:217–22. - PubMed
    1. Gorschluter M, Glasmacher A, Hahn C, Leutner C, Marklein G, Remig J, Schmidt-Wolf IG, Sauerbruch T. Severe abdominal infections in neutropenic patients. Cancer Invest. 2001;19:669–77. doi: 10.1081/CNV-100106141. - DOI - PubMed
    1. Buyukasik Y, Ozcebe OI, Haznedaroglu IC, Sayinalp N, Soylu AR, Ozdemir O, Dundar S. Neutropenic enterocolitis in adult leukemias. Int J Hematol. 1997;66:47–55. doi: 10.1016/S0925-5710(97)00586-0. - DOI - PubMed

Publication types